跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOCDURNA ORAL LYOPHILISATE 25MCG - PPB Drug Approval Details
Approvals
/
PPB
/
NOCDURNA ORAL LYOPHILISATE 25MCG
Approved
STANDARD
NOCDURNA ORAL LYOPHILISATE 25MCG
FERRING PHARMACEUTICALS LTD
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
73971d3a340e6d7c
Company
FERRING PHARMACEUTICALS LTD
Type
Standard
Approval Details
Approval Id
73971d3a340e6d7c
Product Name
NOCDURNA ORAL LYOPHILISATE 25MCG
Drug Hk Name
NOCDURNA ORAL LYOPHILISATE 25MCG
Registration Code
HK-65129
Company Name
FERRING PHARMACEUTICALS LTD
Company Detail Path
/organization/ferring-pharmaceuticals-inc
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2017-05-11
Company Address
SUITE 3301, 33/F, AIA KOWLOON TOWER, LANDMARK EAST, 100, HOW MING STREET, KWUN TONG, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
73971d3a340e6d7c
Type
Standard
Back to PPB Approvals